MGLN Magellan Health Inc

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES                                                                                   
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940                       

1. Name and Address of Reporting Person * Haddock David	2. Issuer Name and Ticker or Trading Symbol MAGELLAN HEALTH INC [ MGLN ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director                    _____ 10% Owner __X__ Officer (give title below)    _____ Other (specify below) General Counsel & Secretary
(Last)          (First)          (Middle) 4801 EAST WASHINGTON STREET	3. Date of Earliest Transaction (MM/DD/YYYY) 3/2/2021
(Street) PHOENIX, AZ 85034 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Common Stock, $0.01 par value	3/2/2021		M(1)		4237	A	$0.00 (2)	4237	D
Ordinary Common Stock, $0.01 par value	3/2/2021		F(3)		1276	D	$93.00 (4)	2961	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0.00 (2)	3/2/2021		M (1)			4237	3/2/2021 (5)	(2)	Common Stock	4237	$0.00 (2)	8473	D
Restricted Stock Units	$0.00 (2)	3/3/2021		A		11309		(6)	(2)	Common Stock	11309	$0.00 (2)	11309	D

Explanation of Responses:
(1)	This transaction was effectuated by a one-third vesting of the Restricted Stock Unit Award granted on March 2, 2020. Each Restricted Stock Unit represents a contingent right to receive one share of Magellan common stock.
(2)	Not applicable.
(3)	Represents the portion of shares withheld by the Company in order to pay taxes.
(4)	Closing price on NASDAQ on March 2, 2021.
(5)	The remainder of 8,473 Restricted Stock Units shall vest in equal increments on March 2, 2022 and 2023.
(6)	Restricted Stock Units shall vest in one third increments on each of March 3 of 2022, 2023 and 2024.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Haddock David 4801 EAST WASHINGTON STREET PHOENIX, AZ 85034			General Counsel & Secretary

Signatures
/s/ David Haddock		3/4/2021
**Signature of Reporting Person		Date